• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对一种来自尿毒症患者血清、可诱导胰岛素抵抗的因子的特性鉴定及部分纯化。

Characterization and partial purification of a factor from uremic human serum that induces insulin resistance.

作者信息

McCaleb M L, Izzo M S, Lockwood D H

出版信息

J Clin Invest. 1985 Feb;75(2):391-6. doi: 10.1172/JCI111712.

DOI:10.1172/JCI111712
PMID:3882760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC423502/
Abstract

We have previously shown that the incubation of normal rat adipose tissue with sera from nondialyzed, nondiabetic uremic patients reduces the transport and metabolism of glucose, in the absence and presence of insulin. In this study insulin-stimulated glucose metabolism by normal rat adipocytes was used as a bioassay to identify the resistance activity, assess the effect of chemical modification on it, and the clinical states associated with its production. The resistance activity was trypsin-labile and had an apparent isoelectric point between 6 and 7, but was not retained by either protein A or concanavalin A columns. The insulin resistance activity was decreased by coincubation with the protein synthesis inhibitor, cycloheximide. Purification to greater than 200,000-fold was attained by heating (100 degrees C) uremic serum, subjecting the supernatant to Sephadex G-25 chromatography and subsequent adsorption to DEAE at pH 7.8 and elution at pH 6.5. The partially purified resistance activity was retained within dialysis tubing of 1,000-mol wt cutoff but not within 2,000-mol wt cutoff. Hemodialysis of patients over 1 wk to 18 mo reduced significantly the amount of resistance activity in their sera. The resistance activity, present in most uremic patients, was not found in the sera of individuals with normal renal function but who were either obese, fasted, elderly or had type II diabetes mellitus. Thus, a circulating small molecular weight peptide, unique to uremia, induced insulin resistance by a protein synthesis-dependent mechanism.

摘要

我们之前已经表明,将正常大鼠脂肪组织与未透析的非糖尿病尿毒症患者的血清一起孵育,无论有无胰岛素,都会降低葡萄糖的转运和代谢。在本研究中,正常大鼠脂肪细胞的胰岛素刺激葡萄糖代谢被用作生物测定法,以鉴定抵抗活性,评估化学修饰对其的影响以及与其产生相关的临床状态。该抵抗活性对胰蛋白酶敏感,表观等电点在6至7之间,但既不被蛋白A柱也不被伴刀豆球蛋白A柱保留。与蛋白质合成抑制剂环己酰亚胺共同孵育可降低胰岛素抵抗活性。通过加热(100℃)尿毒症血清、将上清液进行葡聚糖凝胶G-25层析,随后在pH 7.8吸附到DEAE并在pH 6.5洗脱,可实现纯化至超过200,000倍。部分纯化的抵抗活性保留在截留分子量为1000的透析袋内,但不保留在截留分子量为2000的透析袋内。患者进行1周至18个月的血液透析可显著降低其血清中抵抗活性的量。大多数尿毒症患者血清中存在的抵抗活性,在肾功能正常但肥胖、禁食、年老或患有II型糖尿病的个体血清中未发现。因此,一种尿毒症特有的循环小分子肽通过蛋白质合成依赖性机制诱导胰岛素抵抗。

相似文献

1
Characterization and partial purification of a factor from uremic human serum that induces insulin resistance.对一种来自尿毒症患者血清、可诱导胰岛素抵抗的因子的特性鉴定及部分纯化。
J Clin Invest. 1985 Feb;75(2):391-6. doi: 10.1172/JCI111712.
2
Induction of insulin resistance in normal adipose tissue by uremic human serum.尿毒症患者血清诱导正常脂肪组织产生胰岛素抵抗。
Kidney Int. 1984 Feb;25(2):416-21. doi: 10.1038/ki.1984.33.
3
Somatomedin inhibitor in uremia.尿毒症中的生长调节素抑制剂。
J Clin Endocrinol Metab. 1984 Oct;59(4):764-72. doi: 10.1210/jcem-59-4-764.
4
Cellular basis of insulin resistance in chronic uremia.慢性尿毒症中胰岛素抵抗的细胞基础。
Am J Physiol. 1983 Aug;245(2):E178-84. doi: 10.1152/ajpendo.1983.245.2.E178.
5
Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.从人血浆中对一种微酸性胰岛素样肽(ILA)进行部分纯化、特性鉴定及分析。
J Clin Endocrinol Metab. 1978 Dec;47(6):1240-50. doi: 10.1210/jcem-47-6-1240.
6
Postbinding defects of insulin action in human adipocytes from uremic patients.尿毒症患者人体脂肪细胞中胰岛素作用的结合后缺陷。
Kidney Int. 1985 May;27(5):780-4. doi: 10.1038/ki.1985.80.
7
In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.体内二甲双胍治疗可改善胰岛素抵抗:肥胖(fa/fa) Zucker大鼠脂肪细胞中胰岛素诱导的转位增强及葡萄糖转运蛋白功能活性增加的证据。
Endocrinology. 1993 Jul;133(1):304-11. doi: 10.1210/endo.133.1.8391425.
8
Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.尿毒症中免疫反应的体液抑制剂。II. 尿毒症血清中一种免疫抑制因子的进一步特性分析。
Am J Pathol. 1979 Nov;97(2):277-90.
9
Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.胰岛素对伴有和不伴有非胰岛素依赖型糖尿病的正常及肥胖人类培养脂肪细胞中葡萄糖转运和胰岛素结合的长期影响。
J Clin Invest. 1987 Oct;80(4):1073-81. doi: 10.1172/JCI113163.
10
In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.从非胰岛素依赖型糖尿病患者中分离出的人脂肪细胞的体外胰岛素抵抗
J Clin Invest. 1983 Oct;72(4):1246-54. doi: 10.1172/JCI111080.

引用本文的文献

1
Maximum insulin dose in patients admitted to the intensive care units with severe COVID-19 in the "Cross ICU Searchable Information System" study: A multicenter retrospective cohort study.“跨重症监护病房可检索信息系统”研究中重症新型冠状病毒肺炎(COVID-19)患者入住重症监护病房时的最大胰岛素剂量:一项多中心回顾性队列研究
J Diabetes Investig. 2025 Mar;16(3):555-560. doi: 10.1111/jdi.14380. Epub 2024 Dec 10.
2
Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician.基层医疗医生对晚期慢性肾脏病患者2型糖尿病的治疗
Cureus. 2024 Jul 16;16(7):e64663. doi: 10.7759/cureus.64663. eCollection 2024 Jul.
3
Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease.糖尿病、多囊肾病或晚期肝病患者的腹膜透析护理
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):139-146. doi: 10.2215/CJN.0000000000000420. Epub 2024 Jan 8.
4
Insulin and the kidneys: a contemporary view on the molecular basis.胰岛素与肾脏:分子基础的当代观点
Front Nephrol. 2023 Aug 3;3:1133352. doi: 10.3389/fneph.2023.1133352. eCollection 2023.
5
Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.粪便微生物移植在减少肾脏病中尿毒症毒素积累方面的作用:当前的认识和未来展望。
Toxins (Basel). 2023 Jan 31;15(2):115. doi: 10.3390/toxins15020115.
6
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.使用连续血糖监测评估和管理糖尿病及慢性肾脏病患者。
Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022.
7
Diabetes mellitus in dialysis and renal transplantation.透析与肾移植中的糖尿病
Ther Adv Endocrinol Metab. 2021 Oct 5;12:20420188211048663. doi: 10.1177/20420188211048663. eCollection 2021.
8
Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease.肾脏疾病中的血糖稳态、低血糖和糖尿病现象耗竭。
Semin Nephrol. 2021 Mar;41(2):96-103. doi: 10.1016/j.semnephrol.2021.03.004.
9
Temporal Trends of Severe Hypoglycemia and Subsequent Mortality in Patients with Advanced Diabetic Kidney Diseases Transitioning to Dialysis.晚期糖尿病肾病患者转为透析后严重低血糖及随后死亡率的时间趋势
J Clin Med. 2019 Mar 27;8(4):420. doi: 10.3390/jcm8040420.
10
The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.共病对 2 型糖尿病药物治疗管理的影响。
Drugs. 2019 Feb;79(3):231-242. doi: 10.1007/s40265-019-1061-4.

本文引用的文献

1
STUDY OF THE EFFECT OF UREMIC METABOLITES ON ERYTHROCYTE GLYCOLYSIS.尿毒症代谢产物对红细胞糖酵解影响的研究。
Metabolism. 1964 Jul;13:629-35. doi: 10.1016/0026-0495(64)90071-x.
2
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.分离脂肪细胞的代谢。I. 激素对葡萄糖代谢和脂肪分解的影响。
J Biol Chem. 1964 Feb;239:375-80.
3
An insulin antagonist associated with plasma-albumin.一种与血浆白蛋白相关的胰岛素拮抗剂。
Lancet. 1961 Apr 15;1(7181):804-6. doi: 10.1016/s0140-6736(61)90122-2.
4
Further characterization of an insulin antagonist in the serum of patients in diabetic acidosis.糖尿病酸中毒患者血清中胰岛素拮抗剂的进一步特征分析。
J Clin Invest. 1957 Nov;36(11):1588-93. doi: 10.1172/JCI103557.
5
Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.内毒素诱导的渗出细胞介质对3T3-L1细胞中脂蛋白脂肪酶的抑制作用。
Proc Natl Acad Sci U S A. 1982 Feb;79(3):912-6. doi: 10.1073/pnas.79.3.912.
6
Metabolic alterations caused by uraemia.尿毒症引起的代谢改变。
Proc Eur Dial Transplant Assoc. 1980;17:577-86.
7
Studies of insulin resistance in adipocytes induced by macrophage mediator.巨噬细胞介质诱导的脂肪细胞胰岛素抵抗研究。
J Exp Med. 1983 Apr 1;157(4):1360-5. doi: 10.1084/jem.157.4.1360.
8
Insulin resistance in uremia mediated by postbinding defects.尿毒症中的胰岛素抵抗由结合后缺陷介导。
Kidney Int. 1982 Jul;22(1):54-62. doi: 10.1038/ki.1982.132.
9
Induction of insulin resistance in normal adipose tissue by uremic human serum.尿毒症患者血清诱导正常脂肪组织产生胰岛素抵抗。
Kidney Int. 1984 Feb;25(2):416-21. doi: 10.1038/ki.1984.33.
10
A postbinding inhibitor of insulin action. Increased concentrations in the plasma of non-insulin-dependent diabetic subjects.胰岛素作用的结合后抑制剂。在非胰岛素依赖型糖尿病患者血浆中的浓度升高。
Diabetes. 1984 May;33(5):450-4. doi: 10.2337/diab.33.5.450.